Handelsbanken Fonder’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
ACM
KGAMU
JCM
Handelsbanken Fonder's CDLX Position: Q2 2022 in Review
Handelsbanken Fonder sold out of Cardlytics (CDLX) in Q2 2022, closing a stake of 600 shares — an estimated $330K sold.
Handelsbanken Fonder first reported a position in CDLX in Q3 2020 and held it in 7 quarters. The position peaked at $742K in Q4 2020. 138 funds tracked by Wall St. Rank hold CDLX as of Q2 2022.
- Handelsbanken Fonder reported no remaining Cardlytics position as of Q2 2022 after selling out during the quarter.
- Handelsbanken Fonder sold 600 Cardlytics shares in Q2 2022, an estimated $330K.
- Handelsbanken Fonder first reported a position in Cardlytics in Q3 2020 and held it in 7 quarters.
- Handelsbanken Fonder's Cardlytics position peaked at $742K in Q4 2020.
- 138 funds tracked by Wall St. Rank held Cardlytics as of Q2 2022.
Based on Handelsbanken Fonder's 13F filing for Q2 2022, filed 3 Aug 2022.